(2022). Association between mirtazapine use and serious self-harm in people with depression: an active comparator cohort study using UK electronic health records. Evid Based Ment Health, 25, 169-176. http://doi.org/10.1136/ebmental-2021-300355.
(2022). Comparing the number and length of primary care consultations in people with and without intellectual disabilities and health needs: observational cohort study using electronic health records. Fam Pract. http://doi.org/10.1093/fampra/cmac135.
(2022). Health Needs and Their Relationship with Life Expectancy in People with and without Intellectual Disabilities in England. Int J Environ Res Public Health, 19. http://doi.org/10.3390/ijerph19116602.
(2022). The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records. Bmc Med, 20, 43. http://doi.org/10.1186/s12916-022-02247-x.
(2020). Incidence of Depression and First-Line Antidepressant Therapy in People with Obesity and Depression in Primary Care. Obesity (Silver Spring). http://doi.org/10.1002/oby.22772.
(2021). Safety of antidepressants in a primary care cohort of adults with obesity and depression. PLoS One. http://doi.org/10.1371/journal.pone.0245722.
(2021). Mortality disparities and deprivation among people with intellectual disabilities in England: 2000-2019. J Epidemiol Community Health. http://doi.org/10.1136/jech-2021-216798.